Prescription behaviour of short-acting ß2-agonists in Switzerland
C. Schuoler (Baar, Switzerland), C. Steurer-Stey (Zurich, Switzerland), E. Ullmer (Bern, Switzerland), R. Providoli (Sierre, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), G. Pendl (Baar, Switzerland)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Schuoler (Baar, Switzerland), C. Steurer-Stey (Zurich, Switzerland), E. Ullmer (Bern, Switzerland), R. Providoli (Sierre, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), G. Pendl (Baar, Switzerland). Prescription behaviour of short-acting ß2-agonists in Switzerland. 2640
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: